Suppr超能文献

新型 K-Ras G12C 开关 II 型共价结合物使 Ras 失稳并加速核苷酸交换。

Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange.

机构信息

Department of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco , San Francisco, California 94158, United States.

Department of Biochemistry and Microbiology. University of Victoria , Victoria, BC V8W 2Y2, Canada.

出版信息

J Chem Inf Model. 2018 Feb 26;58(2):464-471. doi: 10.1021/acs.jcim.7b00399. Epub 2018 Jan 31.

Abstract

The success of targeted covalent inhibitors in the global pharmaceutical industry has led to a resurgence of covalent drug discovery. However, covalent inhibitor design for flexible binding sites remains a difficult task due to a lack of methodological development. Here, we compared covalent docking to empirical electrophile screening against the highly dynamic target K-Ras. While the overall hit rate of both methods was comparable, we were able to rapidly progress a docking hit to a potent irreversible covalent binder that modifies the inactive, GDP-bound state of K-Ras. Hydrogen-deuterium exchange mass spectrometry was used to probe the protein dynamics of compound binding to the switch-II pocket and subsequent destabilization of the nucleotide-binding region. SOS-mediated nucleotide exchange assays showed that, contrary to prior switch-II pocket inhibitors, these new compounds appear to accelerate nucleotide exchange. This study highlights the efficiency of covalent docking as a tool for the discovery of chemically novel hits against challenging targets.

摘要

靶向共价抑制剂在全球制药行业的成功,使得共价药物研发重新兴起。然而,由于缺乏方法学的发展,针对柔性结合位点的共价抑制剂设计仍然是一项艰巨的任务。在这里,我们比较了共价对接和针对高度动态靶标 K-Ras 的经验性亲电筛选。虽然两种方法的总命中率相当,但我们能够迅速将对接命中物转化为一种有效的、不可逆的共价结合物,修饰 K-Ras 的无活性 GDP 结合状态。氢氘交换质谱用于探测化合物与开关 II 口袋的结合以及随后核苷酸结合区域的失稳的蛋白质动力学。SOS 介导的核苷酸交换测定表明,与先前的开关 II 口袋抑制剂相反,这些新化合物似乎能加速核苷酸交换。这项研究强调了共价对接作为一种工具,用于发现针对具有挑战性的靶标的具有化学新颖性的命中物的效率。

相似文献

3
Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States.Ras Binder 诱导 GTP 和 GDP 状态下的变构 II 口袋。
Cell Chem Biol. 2017 Dec 21;24(12):1455-1466.e14. doi: 10.1016/j.chembiol.2017.08.025. Epub 2017 Oct 12.
4
Modeling receptor flexibility in the structure-based design of KRAS inhibitors.基于结构的 KRAS 抑制剂设计中的受体柔性建模。
J Comput Aided Mol Des. 2022 Aug;36(8):591-604. doi: 10.1007/s10822-022-00467-0. Epub 2022 Aug 5.
8
Structural Dynamics in Ras and Related Proteins upon Nucleotide Switching.核苷酸转换时Ras及相关蛋白中的结构动力学
J Mol Biol. 2016 Nov 20;428(23):4723-4735. doi: 10.1016/j.jmb.2016.10.017. Epub 2016 Oct 14.
10
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C.强效且选择性的 KRAS G12C 半胱氨酸共价抑制剂。
Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3. doi: 10.1016/j.chembiol.2017.06.017. Epub 2017 Aug 3.

引用本文的文献

10
Advances in covalent drug discovery.共价药物发现的进展。
Nat Rev Drug Discov. 2022 Dec;21(12):881-898. doi: 10.1038/s41573-022-00542-z. Epub 2022 Aug 25.

本文引用的文献

1
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C.强效且选择性的 KRAS G12C 半胱氨酸共价抑制剂。
Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3. doi: 10.1016/j.chembiol.2017.06.017. Epub 2017 Aug 3.
2
Covalent inhibitors design and discovery.共价抑制剂的设计与发现。
Eur J Med Chem. 2017 Sep 29;138:96-114. doi: 10.1016/j.ejmech.2017.06.019. Epub 2017 Jun 10.
3
Expanding the Scope of Electrophiles Capable of Targeting K-Ras Oncogenes.扩大能够靶向K-Ras癌基因的亲电试剂范围。
Biochemistry. 2017 Jun 27;56(25):3178-3183. doi: 10.1021/acs.biochem.7b00271. Epub 2017 Jun 16.
7
Structural Dynamics in Ras and Related Proteins upon Nucleotide Switching.核苷酸转换时Ras及相关蛋白中的结构动力学
J Mol Biol. 2016 Nov 20;428(23):4723-4735. doi: 10.1016/j.jmb.2016.10.017. Epub 2016 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验